cdmo.directory
← Compare landing

Ajinomoto Bio-Pharma Services vs Sinopep-Allsino Biopharmaceutical Co., Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/ajibio-pharma/sinopep

CategoryAjinomoto Bio-Pharma ServicesSinopep-Allsino Biopharmaceutical Co., Ltd.
Listed sitecdmocdmo
SummaryAjinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service.GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.
Services
  • Process Development
  • Small Molecule Development & Manufacturing
  • Biologics Development & Manufacturing
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Quality Control Testing
  • CMC Analytical Development
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Gene Therapy
  • Peptide
  • Peptide
  • Oligonucleotide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Belgium, Belgium, Belgium
  • United States, United States
  • Japan, Japan
  • India, India
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.